Ϫ subgroup C adenovirus (Ad) gene transfer vectors are being used extensively to transfer and express genes in a variety of in vitro and in vivo cell targets (1, 15, 74, 78, 81) . While these vectors are remarkably efficient at transferring the exogenous gene to the target cell nucleus, and while there is usually robust expression of the transferred gene, the interaction of the vector with the cell may also modify the gene expression of the target cell (12, 51, 55, 61); i.e., while the purpose of using E1 Ϫ Ad vectors is to modify the genetic repertoire of the target cell, the vector per se may modify the expression of the endogenous genes of the target. In this regard, in vitro studies with a variety of cell lines show that Ad vectors can induce the target cell to express cytokine genes, prolong or reduce cell survival, and activate intracellular signaling pathways (8, 12, 51, 64, 82) .
E1
Ϫ subgroup C adenovirus (Ad) gene transfer vectors are being used extensively to transfer and express genes in a variety of in vitro and in vivo cell targets (1, 15, 74, 78, 81) . While these vectors are remarkably efficient at transferring the exogenous gene to the target cell nucleus, and while there is usually robust expression of the transferred gene, the interaction of the vector with the cell may also modify the gene expression of the target cell (12, 51, 55, 61) ; i.e., while the purpose of using E1 Ϫ Ad vectors is to modify the genetic repertoire of the target cell, the vector per se may modify the expression of the endogenous genes of the target. In this regard, in vitro studies with a variety of cell lines show that Ad vectors can induce the target cell to express cytokine genes, prolong or reduce cell survival, and activate intracellular signaling pathways (8, 12, 51, 64, 82) .
To begin to develop a broader understanding of the interaction of Ad vectors with target cells, we have used cDNA subtraction analysis to evaluate the cellular genes evoked by the interaction of an E1
Ϫ Ad vector with human umbilical vein endothelial cells (HUVEC). We chose human endothelial cells as the target cells following studies demonstrating that infection of human endothelial cells with E1 Ϫ E4 ϩ Ad vectors (deleted in E1 sequences but retaining E4 sequences) markedly prolongs the survival of endothelial cells in culture, even in the absence of serum (64) . The present study demonstrates that infection of endothelial cells with an E1 Ϫ E4 ϩ AdNull vector, containing an expression cassette with a cytomegalovirus (CMV) early-intermediate promoter-enhancer but no transgene, induces the expression of a variety of endogenous endothelial cell genes, including those coding for intracellular signaling proteins, calcium-regulated and cytoskeletal proteins, growth-regulating proteins, a housekeeping protein, a known expressed sequenced tag (EST), and a novel cDNA. Interestingly, removal of E4 gene sequences from the Ad vector eliminates the Ad modulation of gene expression in endothelial cells, suggesting that one or more E4 gene products play a role in how the Ad vector modifies the expression of genes endogenous to the target cells.
Ad vectors. The Ad vectors used in this study included AdNull (E1
Ϫ E3 Ϫ E4 ϩ ; CMV early-immediate promoter-enhancer, no transgene in the expression cassette) (36) , E4
Ϫ Ad␤gal (E1 Ϫ , E3 Ϫ , E4 Ϫ ; CMV promoter driving the Escherichia coli ␤-galactosidase (␤gal) gene) (7, 82) , and E1 Ϫ E4 ϩ AdGFP (E1 Ϫ E3 Ϫ E4 ϩ ; CMV promoter driving the modified form of the Aeguora victoria green fluorescent protein [GFP] ) (28, 86) . Ad vector stocks were purified by cesium chloride centrifugation and dialysis and quantified by measurement of PFU in 293 cells as previously described (32, 67) . All Ad vectors had a particle/PFU ratio of approximately 100, and all were determined to be free of replication-competent Ad (16) . Clinical grade lipopolysaccharide-and endotoxin-free Ad stocks were used for all the experiments. The optimal doses of Ad vector to express genes in Ͼ90% of HUVEC, fibroblasts, and macrophages were determined by using AdGFP vector and found to be a multiplicity of infection (MOI) of 50 for HUVEC and fibroblasts and 200 for macrophages. These doses were consistent with those in published reports (37, 42, 64) .
Preparation of Ad empty capsids. To prepare Ad devoid of the Ad genome, crude viral lysate of E1 Ϫ E4 ϩ AdNull was prepared and purified by cesium chloride centrifugation as described above (32, 67) . The top band, containing empty capsids, was collected and purified once more by cesium chloride centrifugation, dialyzed, and stored at Ϫ80°C. Spectrophotometric measurements (optical density at 280 nm) were used to calculate the number of empty capsids in the preparation (32 (20) to isolate cDNAs that are differentially expressed in HUVEC infected with the AdNull vector. Briefly, HUVEC were infected with the AdNull vector at a MOI of 50 or mock infected. After 48 h, poly(A) mRNA was isolated. Poly(A) mRNA (2 g) was converted to double-stranded cDNA, digested with RsaI, and ligated to adapters. Control (driver) cDNAs and AdNull-infected HUVEC (tester) cDNAs were hybridized at 68°C for 8 h. Fresh driver cDNA was added to the hybridization mixture to enrich differentially expressed sequences. The subtracted cDNA library was constructed by inserting PCR-amplified subtracted cDNA into the T/A cloning vector (Invitrogen, San Diego, Calif.) and differentially screened individually with [
32 P]dCTP-labeled tester and driver cDNAs. Clones that hybridized strongly with the tester probe but did not hybridize or weakly hybridized to driver probes were isolated and sequenced. BLAST nucleotide homology searches of EST and GenBank nonredundant nucleotide databases were used to help establish the identity of the cDNAs.
Analysis of gene expression. Gene expression of endothelial cells induced by AdNull infection was analyzed by reverse transcription-PCR (RT-PCR) and Northern analysis. Cultures of endothelial cells were infected with AdNull (MOI of 50) for 90 min at 37°C or exposed to medium that did not contain Ad vector; they were then washed to remove virus, and the culture was continued for 24 to 72 h. As controls, endothelial cells were exposed to Ad empty capsids (5,000 particle units per cell) for 90 min at 37°C and washed, and the incubation was continued for 48 h. For comparison to the endothelial cells, fibroblasts and AM were infected with AdNull (MOI of 50 and 200, respectively) for 90 min at 37°C, the cells were washed, and the incubation was continued for 48 h.
RT-PCRs were used to screen gene expression pattern, and when induction of gene expression was observed, it was confirmed by Northern analysis. For RT-PCR, total RNA (200 ng/reaction) extracted from control or Ad vector-infected cells (48 h postinfection) was reverse transcribed and the resulting cDNA was amplified with gene-specific primers (9600 GeneAmp; Perkin-Elmer). The PCR conditions were 94°C for 30 s (denaturing), 56°C for 1 min (annealing), and 68°C for 2 min (elongation) for 30 cycles. Under these optimal PCR conditions, the internal control glyceraldehyde-3-phosphate dehydrogenase (GAPDH; sense primer, CCTTCATTGACCTCAACTACA; antisense primer, GGCAGTGATG GCATGGCATGGACTGT) amplification was linear and did not reach saturation. DNA contamination was ruled out by pretreatment of the samples with DNase (GIBCO BRL) for 15 min at 37°C and by omitting the reverse transcriptase from the PCR as a control.
For Northern analysis, total RNA was isolated with Trizol reagent (Gibco BRL, Gaithersburg, Md.), and 10 g of RNA was transferred to Duralon membranes (Stratagene, La Jolla, Calif.) after electrophoresis through a 1% agarose gel under denaturing conditions. Probes were prepared by using gel-purified cDNA fragments isolated from individual clones and labeled with [ 32 P]dCTP by random priming (Stratagene). Hybridizations were performed in Quickhyb solution (Stratagene) for 2 h at 65°C and were followed by sequential washes in 1ϫ SSC (0.15 M sodium chloride, 0.015 M sodium citrate)-0.1% sodium dodecyl sulfate for 30 min and in 0.1ϫSSC-0.1% sodium dodecyl sulfate for 30 min. Following hybridization, the membranes were analyzed by autoradiography.
RESULTS
Isolation of differentially expressed cDNAs in endothelial cells. cDNAs of genes that were upregulated in the cells infected with the E1 Ϫ E4 ϩ AdNull vector were isolated by differential screening of the subtracted library. Of the 300 clones screened, 30 clones were isolated that hybridized strongly to the total cDNA probes derived from the E1 Ϫ E4 ϩ AdNull vector-infected endothelial cells but did not hybridize or hybridized weakly to total cDNA probes from control uninfected endothelial cells. Of these, 10 cDNAs were identical to previously known sequences, one was identical to a known EST, one was unique (GIA1, for "gene induced by Ad vector") but showed a high homology to the four-and-a-half-lim-only protein (FHL2) gene, and 16 contained sequences that were derived from the E1 Ϫ E4 ϩ AdNull vector (Table 1) . Of the 12 cDNAs selected for further study, all were represented by a single "hit," except for lymphoid blast crisis (LBC) cDNA, which was represented by three independent clones containing different regions of the cDNA. The 12 cDNAs corresponding to known sequences were grouped based on their known functions related to intracellular signaling, calcium-regulated cytoskeletal functions, growth regulation, and housekeeping functions.
To confirm that the different cDNAs were differentially expressed in endothelial cells following infection with an E1 Ϫ
E4
ϩ Ad vector, levels of the mRNAs representing each gene in uninfected control endothelial cells were compared to those in cells infected with the E1 Ϫ E4 ϩ AdNull vector. RT-PCR analysis demonstrated that compared to control uninfected cells, the E1
Ϫ E4 ϩ AdNull vector-infected cells had an induction of expression of LBC, guanine nucleotide binding protein ␣ type S (G␣-S) mitogen kinase 5, (MEK5), calpactin subunits p11 and p36, vinculin, SCA1, insulin-like growth factor binding protein (IGFBP4), and transforming growth factor ␤2 (TGF-␤2), as well as the EST AA557947 and the novel GIA1 gene (Fig. 1) . The control GAPDH RNA levels were similar in the control and E1
Ϫ E4 ϩ Ad vector-infected cells.
Effect of E1
؊ E4 ؉ Ad vector infection on gene expression in other primary human cells. To examine whether the induction of endogenous gene expression by the E1 Ϫ E4 ϩ Ad vector was a general phenomenon or specific to endothelial cells, primary ϩ Ad vector-induced modification of endogenous endothelial cell gene expression, the kinetics of the genes induced by the vector was evaluated by Northern analysis (Fig. 2) . Induction of endogeneous gene expression was first observed 24 h following Ad vector infection. Earlier time points, including 0 h (right after the 90-min infection period [results not shown]) or 6 h postinfection, did not show any induction of gene expression, and the levels were similar to those in uninfected control cells. Several patterns of induction of mRNAs were observed. First, the increased expression of LBC (both 3.0-and 1.7-kb mRNA transcripts) was evident at 24 h postinfection, remained elevated at 48 h, and was declining (but still elevated) by 72 h (Fig.  2) . The same pattern was true for the G␣-S, p11, and p36 subunits of calpactin and EST AA557947. Second, a different pattern was observed for TGF-␤2, with an increased expression of both the 4.0-and 6.0-kb mRNA transcripts at 24 h that continued to rise over the 72 h of observation. Finally, a third pattern of expression induced by the AdNull vector was that seen for the novel cDNA GIA1, where there was elevation of the small transcript (1.7 kb) at 24 h, which then declined as the levels of a larger transcript (2.3 kb) gradually rose over the 72 h of observation. Gene expression in control cells remained unaltered (Fig. 2) .
Endothelial gene expression following addition of empty capsids. Successful infection of target cells by Ad vectors requires initial interaction of the capsid with the cell surface followed by internalization and transport of the vector DNA to host cell nucleus (33, 42, 49, 74, 80) . Since the initial binding of Ad vector capsids to the cell surface is sufficient to activate signal transduction pathways leading to induction of the interleukin-8 gene in HeLa cells (8), we evaluated the effect of empty Ad capsids devoid of vector DNA on endothelial cell gene expression, based on the knowledge that empty capsids (noninfectious Ad particles) bind to target cells in a fashion similar to that of intact, functional Ad (17, 26) . Levels of mRNAs corresponding to the subtracted cDNAs were evaluated by RT-PCR in control cells and cells treated with empty capsids 48 h postinfection (data not shown). Compared to control cells, mRNA levels changed very little, with minimal or no increases in mRNA levels of LBC, G␣-S, MEK5, calpactin subunits p11 and p36, vinculin, SCA1, IGFBP4, and TGF-␤2. The control GAPDH RNA levels also remained unaltered. Thus, elevated expression of the genes represented by the subtracted cDNAs requires an intact Ad vector, suggesting that Ad components other than just the surface capsid play a role in the observed induction of host cell gene expression.
Requirement (Fig. 3) . RT-PCR analysis of total RNA extracted from cells infected with E1
Ϫ E4 ϩ Ad vector showed an E4-specific 360-bp PCR product (Fig. 3A) . In contrast, neither uninfected control endothelial cells nor endothelial cells infected with E1
Ϫ E4 Ϫ Ad vector showed the E4-specific PCR product; i.e., Ad E4 genes are expressed in endothelial cells following infection with an E1 Ϫ E4 ϩ Ad gene transfer vector but not in the E1 Ϫ E4 Ϫ Ad vector-infected or naive control cells.
RT-PCR analysis demonstrated that, in contrast to the E1 Ϫ E4 ϩ Ad vector (Fig. 1) , infection of endothelial cells with an E1 Ϫ E4 Ϫ Ad vector had little effect on endogenous endothelial gene expression (Fig. 3B) . In this regard, while mRNA levels of G␣-S and IGFBP4 were mildly increased in the E1 Ϫ E4 Ϫ Ad vector-infected cells, the mRNA levels of the other genes upregulated by the E1 Ϫ E4 ϩ Ad vector, including the mRNAs for LBC, MEK5, the p11 and p36 subunits of calpactin, vinculin, SCA1, and TGF-␤2, remained unaltered (Fig. 3B) . Northern blot analysis further confirmed the minimal induction of G␣-S expression in E1 Ϫ E4 Ϫ Ad vector-infected cells while calpactin p36 and TGF-␤2 expression remained constant (Fig. 3C) . Thus, while the modulation of G␣-S gene expression may be independent, to some degree, of AdE4 gene products, the induced expression of other genes corresponding to subtracted cDNAs by E1 Ϫ E4 Ϫ Ad vectors appear to require expression of at least some AdE4 gene ORFs.
DISCUSSION
The basic concept underlying the use of any gene transfer strategy is that the vector will deliver the expression cassette with the exogenous gene to the target cell nucleus, where it will be expressed without substantially modifying the integrity and function of the target cell. While it is known that E1 Ϫ E4 ϩ Ad vectors can achieve delivery and expression of exogenous genes to human endothelium in vitro and in vivo with reasonable efficacy (13, 25, 47, 48, 82) , the present study demonstrates that Ϫ E4 ϩ Ad vector (Ad) was used as templates for RT-PCR analysis with gene-specific primers. GAPDH primers were used to confirm RNA integrity and use of equal amounts of RNA. Note that in most cases, there appears to be significant upregulation of expression of the genes identified by the subtraction library.
E1
Ϫ E4 ϩ Ad vectors achieve this at a price, since the vector concomitantly initiates the expression of a number of endogenous endothelial cell genes. By using a subtraction cloning strategy, the data demonstrate that E1 Ϫ E4 ϩ Ad vectors upregulate a variety of genes that appear to be relatively endothelial-cell specific, since the same vector had little effect on other primary human cells such as fibroblasts and AM. Interestingly, empty Ad capsids did not significantly induce endogenous endothelial-cell gene expression, and comparison of E1 Ϫ E4 ϩ and E1 Ϫ E4 Ϫ Ad vectors demonstrated that the induction of endogenous endothelial genes by the E1 Ϫ E4 ϩ Ad vector was linked, to a significant degree, to expression of E4 gene products.
Mechanisms of endothelial-cell upregulation of endogenous genes by E1
؊ E4 ؉ Ad vectors. Ad vector-mediated induction of endothelial-cell gene expression could be mediated either by virus attachment to the cell surface receptors or by Ad viral proteins that are synthesized at very low levels following vector DNA transport to the nucleus. In regard to virus attachment, it has been shown that following addition of an Ad vector to clear. However, it is known that several proteins encoded by the seven E4 ORFs have functions that regulate cellular transcription. For example, ORF3 protein is associated with the nuclear matrix and is required for accumulation of late viral mRNA in the host cell nucleus (5, 69) . ORF6/7 protein modulates the activity of cellular transcription factor E2F (34, 38) . ORF4 regulates phosphorylation of the c-fos component of the AP-1 transcription factor (45, 58) . Finally, there is recent evidence suggesting that E4 genes may play a role in the persistence of expression of transgenes following in vivo transfer with E1
Ϫ Ad vectors (6, 30, 43) . Thus, although expression of E4 gene is significantly reduced in the absence of E1, the low-level expression of the E4 gene in an E1
Ϫ E4 ϩ Ad gene transfer vector seem to be sufficient to modulate cellular as well as transgene expression.
Endothelial-cell genes evoked by Ad vectors. The genes that are upregulated in endothelial cells by an E1 Ϫ E4 ϩ Ad vector encode proteins that are components of intracellular signaling (LBC, G␣-S, and MEK5), the cytoskeleton (vinculin, calpactin subunits p11 and p36, and SCA1), and growth regulation (IGFBP4 and TGF-␤2).
The LBC gene product is known to associate with the GTP binding protein Rho in vivo and functions as a Rho-specific guanine nucleotide exchange factor (84) . Consistent with an in vivo role for LBC in Rho regulation, microinjection of the LBC cDNA into quiescent Swiss 3T3 fibroblasts induces actin stress fiber formation indistinguishable from that induced by Rho (84) .
The G␣-S subunit of the heterotrimeric G-proteins is a GTPase that mediates the rate-limiting hydrolysis of GTP to GDP (19) . G␣-S stimulates adenyl cyclase and increases cellular cyclic AMP levels. Constitutively active mutants of G␣-S-coupled thyrotropin-stimulating hormone receptors have been isolated from hyperfunctioning thyroid adenomas, suggesting a role for G␣-S in the regulation of cell growth (83) . Recent evidence also suggests a growth-inhibitory role for constitutively active G␣-S in MCSF-7 breast carcinoma cells (11) .
The observation that G␣-S expression in endothelial cells is upregulated by the E1 Ϫ E4 ϩ Ad vector is consistent with the upregulation of MEK5 expression by the same vector in the same cells. In this context, it is hypothesized that the constitutively active G␣-S might disrupt downstream mitogen-activated protein (MAP) kinase pathways (44, 53) . In this pathway, Raf (MAP kinase kinase kinase) phosphorylates and activates MEK (MAP kinase kinase), which in turn mediates the activation of ERK1 and ERK2 (MAP kinase). MEK-5, a novel member of the MEK family, phosphorylates a downstream substrate, big MAP kinase (BMK1), which, in turn, activates myocyte-specific enhancer binding factor (MEF2C), resulting in the induction of the immediate-early response gene c-jun (44) . Vinculin, a 16-kDa single-chain cytoskeletal protein, is organized as linear arrays confined to cell-cell contact areas or as plaques in resting and migrating endothelium (57) . Vinculin is a component of a focal adhesion complex which integrates integrin-mediated signaling events (50) . Disruption of this complex results in cell death (50) . Vinculin is a substrate for several serine/threonine and tyrosine kinases (57) and may play a role in cell growth and transformation. In this context, the exposure of normal rabbit arteries to high concentrations of an E1 Ϫ E4 ϩ Ad vector upregulates the expression of the adhesion molecules ICAM-1 and VCAM-1 in vascular smooth muscle cells of the arterial wall (61) .
Calpactins/lipocortines are a family of calcium binding proteins which interact with phospholipids and cytoskeletal proteins, actin, and spectrins (14) . Calpactin I exists as a 36-kDa monomer or as a dimer complexed with an 11-kDa protein (31, 85) . The p36 calpactin heavy chain is phosphorylated at a tyrosine residue in transformed and growth factor-stimulated cells (39, 41) . Interestingly, both p36 and p11 mRNA levels were upregulated in parallel in the E1 Ϫ E4 ϩ Ad-infected endothelial cells. Interestingly, there is persistence of parallel upregulation of both subunits in the TGF-␤2 upregulates both calpectin p11 and p36 subunits (59) . SCA1 (for "spinocerebellar ataxia 1"), a 200-kDa singlechain protein also referred to as ataxin, is expressed in fetal and adult brain. The neurodegenerative disease spinocerebellar ataxia is associated with expansion of CAG codons in the ataxin coding sequence and consequently a long polyglutamine tract in the ataxin protein. The SCA1 gene is expressed as an 11-kb transcript in all tissues examined (3, 73) . We observed that SCA1 is expressed at very low levels in endothelial cells, but the functional role of ataxin in endothelial cells is not known.
Upregulation of IGFBP4 expression by the E1 Ϫ E4 ϩ Ad vector in primary human endothelial cells suggests a role for this protein in endothelial cell growth and survival. In this regard, IGF-I and IGF-II are structurally related to insulin and mediate the growth promoting-effects of growth hormones, they are essential during fetal development (23, 63) . IGF-I is both mitogenic and chemotactic for endothelial cells (4) . IGFs are normally bound to high-affinity binding proteins (IGFBP), which inhibit or potentiate the IGF effect depending on the ambient conditions and cell type (63) . IGFBP4 is one of the members of this family and is synthesized and secreted by bovine arterial, aortic, and microvessel endothelial cells (56) .
The TGF-␤ family includes multifunctional proteins displaying a variety of activities in a cell-specific manner (54) . TGF-␤2, a member of the family, is known to be expressed in endothelial cells (72) . TGF-␤2 is a strong chemoattractant and mitogen for some cell types, but it inhibits endothelial-cell growth and migration (27, 54, 70) .
Glyceraldehyde-6-phosphate dehydrogenase (G6PDH) is a rate-limiting enzyme of the hexose monophosphate shunt (66) . Expression of G6PDH is under nutritional and hormonal control (29, 52, 62) . G6PDH activity is very low under fasting conditions in parenchymal cells, and G6PDH mRNA levels are markedly unregulated following refeeding and insulin administration (52, 62) . Hepatic endothelial cells express a very low level of G6PDH under resting conditions and is stimulated severalfold following administration of bacterial endotoxin (75) . Interestingly, the present study demonstrates that G6PDH mRNA levels are very low in resting HUVEC but that they are upregulated following infection with an E1 Ϫ E4 ϩ Ad vector.
Consequences of E1
؊ E4 ؉ Ad vector modification of gene expression. The specific consequences of the genes observed to be upregulated in endothelial cells by an E1 Ϫ E4 ϩ Ad vector are unknown. The pattern of E1 Ϫ E4 ϩ Ad vector induction of genes appears to have at least some cell specificity, in that none of the genes induced by E1 Ϫ E4 ϩ Ad gene transfer vectors in endothelial cells were upregulated in human primary skin fibroblasts or alveolar macrophages. It is intriguing to speculate on a link between the known function of some of these genes and our recent observation that E1 Ϫ E4 ϩ Ad vectors suppress the proliferation of primary human endothelial cells in vitro and that primary human endothelial cells infected by E1 Ϫ E4 ϩ Ad vectors remained viable for prolonged periods even in the absence of serum and growth factors and independent of the transgene carried by the Ad vector (64) . Further, E1 Ϫ E4 ϩ Ad vectors appear to provide an antiapoptotic signal to endothelial cells, in that infection with the vector results in an increase in the ratio of Bcl2 to Bax levels in the endothelial cells. Although the mechanism of these profound effects of E1 Ϫ E4
ϩ Ad vectors on endothelial-cell survival is unclear, it requires the presence of AdE4 gene products in a fashion similar to that observed in the present study, with the requirement of E4 gene products to induce endothelial-cell genes following infection with the Ad vector.
In view of these observations, at least some of the genes induced by E1 Ϫ E4 ϩ Ad vectors might play a role in the inhibition of endothelial-cell proliferation and survival following Ad vector infection. For example, the signaling molecules LBC, G␣-S, and MEK5 could initiate a cell survival pathway resulting in prolonged survival of Ad infected endothelial cells. In light of evidence suggesting that cytoskeletal organization and the resulting cell shape play a major role in cell attachment to the substratum and cell survival (65), the cytoskeletal proteins vinculin and calpactins p11 and p36 interact with actin and thus could affect endothelial-cell adhesion and cell shape and hence cell survival. Finally, upregulation of TGF-␤2 in Ad-infected endothelial cells might be responsible for the inhibition of cellular DNA synthesis and proliferation.
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